TONIX PHARMACEUTICALS HOLDING CORP. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $79.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $4.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-03-31 was $23.00K, a 20.69% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-03-31 was $29.00K, a 27.50% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $27.00K, a 6.90% decline from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $29.00K, a 27.50% decline from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $40.00K, a 58.33% decline from fiscal 2021.
- TONIX PHARMACEUTICALS HOLDING CORP. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $96.00K, a 4700.00% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $79.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $27.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $4.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $23.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $29.00K 10-K · filed 2025-03-18 | |
| 2023-03-31 | $29.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $40.00K 10-K · filed 2024-04-01 | |
| 2022-03-31 | $40.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $96.00K 10-K · filed 2023-03-13 | |
| 2021-09-30 | $68.00K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $28.00K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $2.00K 10-K · filed 2022-03-14 | |
| 2020-03-31 | $2.00K 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $31.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $28.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $3.00K 10-Q · filed 2020-11-09 | |
| 2017-12-31 | $74.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |